No Data
No Data
Goldman Sachs Sees More China Tariffs in Early 2025 With Trump Set to Return
Bio-Path Holdings, Inc. (BPTH) Q3 2024 Earnings Call Transcript Summary
Bio-Path Holdings, Inc. Expands DNAbilize Technology to Obesity Treatment, Reveals Third Quarter Financial Results
Bio-Path Holdings 3Q Loss/Shr 70c >BPTH
Express News | Bio-Path Q3 Net Income USD -2.1 Million
Bio-Path GAAP EPS of -$0.70
No Data
No Data
PaulG : vste 4.00
Lnova PaulG : It looks shorted